Retrospective study demonstrates improved ankle dorsiflexion in patients with recalcitrant contracture, suggesting high-intensity hydraulic stretching offers a viable non-operative alternative.
Background Ankle contracture/arthrofibrosis is addressed with physical therapy or low-intensity stretch assist splints, requiring prolonged treatment and if clinician-set goals remain unmet, surgical intervention is considered. Mechanical therapy using a hydraulic stretch assist device with a high-intensity stretch protocol offers a potential non-operative alternative. This study evaluated the effectiveness of a hydraulic stretch-assist device in improving ankle dorsiflexion range of motion (ROM). Methods : This retrospective study reviewed patients from an internal database prescribed the Ermi Ankle Flexionater + device between October 2021 and May 2023 after plateauing in dorsiflexion recovery despite at least four weeks of standard treatment Dorsiflexion ROM was measured using the ErmiMotion application in straight- and bent-leg positions at baseline and follow-up. Changes between initial and final measurements were assessed using paired t-tests, with significance set at α< 0.05. Results : Seventy-four patients had complete data available. Treatment began 214 days after injury/surgery. The final dorsiflexion ROM significantly improved in straight (from 4.0°±10.8° to 12.5°±10.2°; p < 0.001) and bent leg positions (from 8.1°±11.7° to 15.0°±10.8°; p < 0.001). Effect sizes were large (Cohen’s d=0.86 and 0.80, respectively). Patients with severe motion loss showed marked improvement (straight: −7.7°±6.5° to 7.3°±11.4°; p < 0.001; bent: −9.1°±10.7° to 9.6°±10.3°; p = 0.001), with very large effect sizes (Cohen’s d=1.52 and 3.06, respectively). Conclusions : Treatment with a hydraulic stretch assist device was associated with improved dorsiflexion ROM in patients with ankle contracture, including those with severe limitations. These findings support consideration of using a hydraulic stretch assist device for individuals who do not respond adequately to standard treatments.
No takes yet. Share an insight, caveat, or question.
Beckley et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: